89196-95-2
89196-95-2
Chemical Structure
RX 801077 hydrochloride
Synonym(s): 2 BFI
- CAS No.: 89196-95-2
- Formula:C11H11ClN2O
- Molecular Weight:222.67
IUPAC Name: 2-(benzofuran-2-yl)-4,5-dihydro-1H-imidazole hydrochloride
InChIKey: RFNFFVDVGWOSNZ-UHFFFAOYSA-N
SMILES: Cl[H].C1(C2=CC3=CC=CC=C3O2)=NCCN1
Biological Activity: RX 801077 hydrochloride (2 BFI) is a selective imidazoline I2 receptor (I2R) agonist with a Ki value of 70.1 nM. RX 801077 hydrochlorideshows anti-inflammation and neuroprotection. RX 801077 hydrochloride has the potential for the research of traumatic brain injury (TBI)[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
RX 801077 hydrochloride | 99.20% | RX 801077 hydrochloride (2 BFI) is a selective imidazoline I2 receptor (I2R) agonist with a Ki value of 70.1 nM. RX 801077 hydrochlorideshows anti-inflammation and neuroprotection. RX 801077 hydrochloride has the potential for the research of traumatic brain injury (TBI). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
RX 801077 hydrochloride (Standard) | ≥98% | RX 801077 (hydrochloride) (Standard) is the analytical standard of RX 801077 (hydrochloride) (HY-100904). This product is intended for research and analytical applications. RX 801077 hydrochloride (2 BFI) is a selective imidazoline I2 receptor (I2R) agonist with a Ki value of 70.1 nM. RX 801077 hydrochlorideshows anti-inflammation and neuroprotection. RX 801077 hydrochloride has the potential for the research of traumatic brain injury (TBI). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Carpéné C, et al. Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites. J Pharmacol Exp Ther. 1995 Feb;272(2):681-8. [Content Brief]
- [2]. Ni H, et al. 2-BFI Provides Neuroprotection Against Inflammation and Necroptosis in a Rat Model of Traumatic Brain Injury. Front Neurosci. 2019 Jun 26;13:674.
